Literature DB >> 2504481

Immunopathology of Schistosoma mansoni infection.

D L Boros1.   

Abstract

Schistosomiasis mansoni is a chronic helminthic disease that affects about 100 million people in the tropics. The worms have a life span of 5 to 10 years, and they live in the mesenteric veins of the host. Lightly infected individuals are asymptomatic or manifest mild intestinal symptoms. Heavily infected individuals often develop severe morbidity with hepatosplenomegaly, sometimes with a fatal outcome. Morbidity is attributed to the strong humoral and T-cell-mediated host immune responses developed to a variety of parasite antigens and expressed as tissue inflammations. The immunopathology includes dermatitis, immune complex-mediated kidney disease, and, chiefly, T-cell-mediated granuloma formation and fibrosis around disseminated parasite eggs. This review describes the mechanisms of induction and expression of immunopathology in infected persons and experimental animals. Immunoregulatory mechanisms that modulate the enhanced immune responses and may ameliorate excessive morbidity are discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2504481      PMCID: PMC358119          DOI: 10.1128/CMR.2.3.250

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  281 in total

1.  Liver collagen hydroxylation in murine schistosomiasis.

Authors:  M A Dunn; M E Maragoudakis; P K Hait
Journal:  Biochim Biophys Acta       Date:  1978-01-18

2.  Veterans medical care: past, present and future.

Authors:  J W Walsh
Journal:  Bol Asoc Med P R       Date:  1973-01

3.  Advanced kidney disease in patients with hepatosplenic Manson's schistosomiasis.

Authors:  T De Brito; J Gunji; M E Camargo; D O Penna; L C Da Silva
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1970 Jul-Aug       Impact factor: 1.846

4.  Schistosoma mansoni: kinetics and class specificity of hypergammaglobulinemia induced during murine infection.

Authors:  A Sher; S McIntyre; F von Lichtenberg
Journal:  Exp Parasitol       Date:  1977-04       Impact factor: 2.011

5.  Immunodiagnosis of recently acquired Schistosoma mansoni infection. A comparison of various immunological techniques.

Authors:  A M Deelder; D Kornelis
Journal:  Trop Geogr Med       Date:  1981-03

6.  Presence of Schistosoma mansoni antigens in liver, spleen and kidney of infected mice: a sequential study.

Authors:  I El-Dosoky; E A Van Marck; A M Deelder
Journal:  Z Parasitenkd       Date:  1984

7.  Modulation of Schistosoma mansoni egg-induced granuloma formation. III. Evidence for an anti-idiotypic, I-J-positive, I-J-restricted, soluble T suppressor factor.

Authors:  T Abe; D G Colley
Journal:  J Immunol       Date:  1984-04       Impact factor: 5.422

8.  Correlation of circulating immune complexes and complement breakdown products with the severity of the disease in human schistosomiasis mansoni.

Authors:  B Galvão-Castro; J C Bina; A Prata; P H Lambert
Journal:  Am J Trop Med Hyg       Date:  1981-11       Impact factor: 2.345

9.  Differences in hepatic fibrosis in ICR, C3H, and C57BL/6 mice infected with Schistosoma mansoni.

Authors:  A W Cheever; M A Dunn; D A Dean; R H Duvall
Journal:  Am J Trop Med Hyg       Date:  1983-11       Impact factor: 2.345

10.  The Katayama syndrome in Saudis.

Authors:  A E Mohamed
Journal:  J Trop Med Hyg       Date:  1985-10
View more
  70 in total

Review 1.  Schistosomiasis--a century searching for chemotherapeutic drugs.

Authors:  Gabriela Ribeiro-dos-Santos; Sergio Verjovski-Almeida; Luciana C C Leite
Journal:  Parasitol Res       Date:  2006-04-25       Impact factor: 2.289

Review 2.  Curse of schistosomiasis on Egyptian liver.

Authors:  Abdel-Rahman El-Zayadi
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742

3.  Schistosomal egg antigen-responsive CD8 T-cell population in Schistosoma mansoni-infected BALB/c mice.

Authors:  V Pancré; M Delacre; J Herno; C Auriault
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

4.  Tranilast ameliorates impaired hepatic functions in Schistosoma mansoni-infected mice.

Authors:  Eman Said; Shehta A Said; Wagdi F Elkashef; Nariman M Gameil; Elsayed M Ammar
Journal:  Inflammopharmacology       Date:  2012-01-26       Impact factor: 4.473

Review 5.  Tropical medicine.

Authors:  G C Cook
Journal:  Postgrad Med J       Date:  1991-09       Impact factor: 2.401

6.  Polarization of the immune response to the single immunodominant epitope of p38, a major Schistosoma mansoni egg antigen, generates Th1- or Th2-type cytokines and granulomas.

Authors:  Y Chen; D L Boros
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

7.  Identification of paramyosin T cell epitopes associated with human resistance to Schistosoma mansoni reinfection.

Authors:  C T Fonseca; E Cunha-Neto; A C Goldberg; J Kalil; A R de Jesus; E M Carvalho; R Correa-Oliveira; J Hammer; J Sidney; A Sette; S C Oliveira
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

8.  An improved noninfectious murine skin model of organized granulomatous inflammation.

Authors:  T Iida; Y Nozaki; K Fukuyama; W L Epstein
Journal:  Experientia       Date:  1991-03-15

9.  Upregulation of cannabinoid receptor-1 and fibrotic activation of mouse hepatic stellate cells during Schistosoma J. infection: role of NADPH oxidase.

Authors:  Mi Wang; Justine M Abais; Nan Meng; Yang Zhang; Joseph K Ritter; Pin-Lan Li; Wang-Xian Tang
Journal:  Free Radic Biol Med       Date:  2014-03-19       Impact factor: 7.376

10.  Interference with hemozoin formation represents an important mechanism of schistosomicidal action of antimalarial quinoline methanols.

Authors:  Juliana B R Corrêa Soares; Diego Menezes; Marcos A Vannier-Santos; Antonio Ferreira-Pereira; Giulliana T Almeida; Thiago M Venancio; Sergio Verjovski-Almeida; Vincent K Zishiri; David Kuter; Roger Hunter; Timothy J Egan; Marcus F Oliveira
Journal:  PLoS Negl Trop Dis       Date:  2009-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.